FDA’s latest CGT guidance streamlines path for in vivo CAR-T development
The FDA has released three new guidance documents on cell and gene therapy development, covering clinical trial design and post-market studies.
22 October 2025
22 October 2025
The FDA has released three new guidance documents on cell and gene therapy development, covering clinical trial design and post-market studies.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.